(Page 2 of 2)
to a scientific audience that it was a hybrid compound with two ways of working, and that it looked and sounded like “vitality.” The part that made it sound like a hybrid is important to physicians who are used to seeing depression drugs that are pretty much all alike, while the “vitality” part sounds good to a patient who wants help with depression.
If you are Seattle Genetics, and selling a new drug for Hodgkin’s disease and other rare, deadly lymphoma, you don’t really need to appeal to the consumer masses. That’s partly why the company settled on “Adcetris” for its new drug. The thinking was that for physician/scientists, starting the name with the letters ADC would call to mind the drug’s scientific origins as an antibody drug conjugate. That’s a jargon term that Seattle Genetics has used for years to describe its technique of linking, or “conjugating” an antibody to a toxin that makes the drug more potent.
I’ve written about antibody drug conjugates for years, and personally didn’t get the ADC connection at first glance. And I joked with Bruce Seeley, Seattle Genetics’ executive vice president of commercial operations, that I accidentally typed “Adcentris” a couple times before I could get the spelling right. It didn’t seem to bug him—he said the team at Seattle Genetics is happy that the FDA agreed to allow “Adcetris” to stand.
“I’ve named quite a few products in my history, and it’s increasingly difficult to find an attractive name that doesn’t sound like something else, or have a patient safety issue associated with it,” Seeley says. “We’re very fortunate.”
I thought it would be fun to comb through a list of recent names of drugs that have been FDA approved, or newly coined by the manufacturers, to give you a chance to weigh in on which ones you like, and which ones you don’t. There are 18 new drugs listed in the chart below. Below the chart, you can vote on the best and worst names in the bunch. Of course, you’re also welcome to leave your comments at the bottom of this story, too. This is an entirely unscientific poll, but it seems like fun. Who knows, if this exercise uncovers some fun new facts or insights, I might even share the results in a future BioBeat column. That is, so long as all these drug names haven’t already put you to sleep.
| Scientific name | Brand Name | Disease | Company |
| telaprevir | Incivek | Hepatitis C | Vertex Pharmaceuticals |
| boceprevir | Victrelis | Hepatitis C | Merck |
| brentuximab vedotin | Adcetris | Hodgkin’s disease | Seattle Genetics |
| abiraterone | Zytiga | Prostate cancer | Johnson & Johnson |
| cabazitaxel | Jevtana | Prostate cancer | Sanofi-Aventis |
| belimumab | Benlysta | Lupus | Human Genome Sciences |
| denosumab | Prolia | Osteoporosis | Amgen |
| denosumab | Xgeva | Cancer-related bone fractures | Amgen |
| sipuleucel-T | Provenge | Prostate Cancer | Dendreon |
| gabapentin enacarbil | Horizant | Restless Legs Syndrome | Xenoport |
| gabapentin | Gralise | Postherpetic neuralgia | Depomed |
| peginterferon alfa-2b | Sylatron | Melanoma | Merck |
| ipilimumab | Yervoy | Metastatic melanoma | Bristol-Myers Squibb |
| ibuprofen and famotidine | Duexis | Osteoarthritis, rheumatoid arthritis | Horizon Pharma |
| tocilizumab | Actemra | Rheumatoid arthritis | Roche |
| roflumilast | Daliresp | Chronic Obstructive Pulmonary Disease | Forest Laboratories |
| vilazodone | Viibryd | Depression | Clinical Data |
| azilsartan medoxomil | Edarbi | Hypertension | Takeda Pharmaceuticals |
Create your free online surveys with SurveyMonkey, the world’s leading questionnaire tool.
Create your free online surveys with SurveyMonkey, the world’s leading questionnaire tool.
By posting a comment, you agree to our terms and conditions.
Sponsored · Whitepaper
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace
Amen, brother. As a pharma marketer, it seems to me the objective is to occupy a space in the mind of the prescriber on the way to “top of mind in the category.” Being uniquely odd just isn’t aiming high enough. One suspects that professional namers are simply keyboarding parameters into a program, letting it run and editing out the candidates with no vowels at all. Does this work? Sure. But naming could be done so much better.
Drum roll please….the votes are in on the best and worst drug names. Here are the top 10 worst names, as selected by you the readers by 6 pm Eastern/3 pm Pacific time.
Worst:
Xgeva….27
Yervoy…20
Edarbi…16
Viibryd..10
Incivek…8
Zytiga….5
Duexis….5
Daliresp..5
Actemra…4
Victrelis.4
Jevtana…3
Adcetris..2
Provenge..2
Horizant..2
Gralise….2
Sylatron..2
I’ll add another comment for the names you voted in as the best.
Here are the votes for the best drug names:
Best:
Provenge…39
Benlysta…27
Prolia…..21
Incivek….10
Horizant….9
Victrelis…8
Viibryd…..7
Adcetris….5
Yervoy……4
Actemra…..4
The polls are now closed. SurveyMonkey wants me to pay for more results, and since this was just for fun, I’m not going to. I’m not sure what to conclude here, other than we have a lot of Dendreon fans stuffing the ballot box, like many probably will for Ichiro at this year’s All-Star game. Thanks for sharing your thoughts!
Viibryd sounds like a new humanoid species in a science fiction universe…
i also voted for Provenge as the one i like most because its an action name..the revenge of of the prostate to ward off cancer cells.easier for the doctors to recall and “feel good” for patients.I dont like Galise because in the Philippines Galis is a stubborn wound.It should avoid this connotation if it wants to gain a good international brand image.Overall thank you for the mental exercise.
In fact, it sounds like proactive revenge. Vengeance carried out even before the need for re-venge.
It is Gralise, not Galise. And it is now Depomed’s, not Abbott’s.
LJ—good catch, thanks. After writing this, I also realize I forgot a few drugs that would have been fun to include in the mix. I’m thinking of Arena Pharmaceuticals’ lorcaserin (Lorqess) for obesity, Orexigen Therapeutics’ combination of naltrexone and bupropion (Contrave) for obesity, Amylin Pharmaceuticals exenatide once-weekly (Bydureon) for diabetes, and Optimer Pharmaceuticals’ fidaxomicin (Dificid) for C. difficile infections.
Completely agree. Naming products in the pharma space is so much more cpmplex as there are even more criteria to consider beyond brand image and the basic marketing criteria. All the good ones are taken. Not surprised about the results of the poll. The best names are still easy to pronounce and spell. Even in pharma.
Nice post. Well done.
I am baffled by half of the names of the newer medications being advertised: Yaz, Beyaz, Lyrica, et al. When I think of “Lyrica,” I think of someone or something singing. “Lyrica” has no relation to fibromyalgia, but then again, the name Tylenol doesn’t “scream” headache, either.
And Yaz? Ever since problems were reported with Yaz we can “BE Yaz?” What the….?
Yaz is short for Yastremski, as in Carl. The great Red Sox outfielder.
tocilizumab, denosumab, ipilimumab… how about yabbadabbadomobabababy?
Lets be sensitive, there’s been a lot of violence in the Edarbi region lately…
New drug names are making me furious!! The fury began with Latuda. (????) WhoTF came up with that gem? Need to adjust adjust your la-atti-tuda?!? I hate it, I hate it so much. I hate it beyond words. It makes my head ache. Next, I heard (and also hated) Januvia. Is that Latuda’s sister? WTF?!? Just heard an ad for Harvoni. Reeeaally?? Huh, that must be Victoza’s brother. WhoTF is naming this f’d up family?!? You can’t be serious. These are the stupidest, most annoying drug names in the history of drug names. I don’t care what ailment I develop, I’d rather suffer with whatever-it-is than take one of these absurdly, asininely, ridiculously named drugs. Really, I won’t take them based on their names alone. I won’t, I will not… ever.
Wait…. Will any of these meds prevent a stroke?!?!? Merely hearing them is about to give me one.
So, in other words, it’s a [email protected] story. I have never been able to pronounce my Omeprazole with success and know I know it’s some stupid [email protected] making $hit up. It makes me want to throw up. The Pharm colleges need to create an atmosphere where they become adjudicate. These [email protected] make me want to puke.
Pharm guys, we get your acumen and your education. You don’t need to confuse old people with legitimist prognition and pretend BULLSHIT. God, where the days when honest men and women tried to help people, when the learned tried to heal, when self advancing men and women loved to be helpful. GODD DAMN YOU ALL. You are a blight on this civilization. Money hungry FUCKS.
I hate these effing names. The drug companies think they’re so cute. Some A-hole stays up all night thinking of this crap.
Useful comments – I learned a lot from the analysis – Does anyone know where my company could possibly locate a blank a form document to fill in ?
Forgive the rimjob I’m about to give you, but this is a very well written article and I wish all people would write like this.